drugset / Trial / NCT06061575

Comparison of the Efficacy of Paracetamol and Ibuprofen in the Management of Fever in Sepsis Patients

NCT06061575

Phase 4 Completed 113 enrolled Ankara City Hospital Bilkent
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a randomized double-blind controlled study with the primary aim of scientifically evaluating the potential effects of paracetamol and ibuprofen in the management of sepsis by comparing their fever-reducing efficacy in septic patients. Sepsis is recognized as a severe form of systemic inflammatory response syndrome (SIRS) characterized by organ dysfunction resulting from severe infections. This study aims to address a significant aspect of fever management in septic patients by objectively assessing the fever-reducing potential of paracetamol and ibuprofen.

Timeline

Start
2023-10-31
Primary completion
2024-10-31
Completion
2024-12-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1 g
Subject Ibuprofen Small molecule 400 mg